Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

Using electronic health records can help identify drug side effects but has some limitations.

Many patients with Giant Cell Arteritis did not follow their steroid treatment plans properly.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Blocking a protein called prostaglandin D2 might help treat hair loss.

The Oat mouse model shows mild retinal degeneration, useful for testing treatments.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Nuclear AR levels give better insight into hormone effects in skin conditions.

Adrenocorticotropic hormone inhibits growth and affects body composition in male rats.

A new method helps detect androgen receptor movement in cells, aiding research on hair loss treatments.

AHR ligands could treat inflammatory skin diseases.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

AH-001 could be a safer and more effective treatment for hair loss.

A new diagnostic model can help better diagnose and understand Alopecia Areata.

Imaging helps detect adrenal gland issues and monitor treatment in congenital adrenal hyperplasia, and can identify tumors affecting fertility.

GLP-1RA therapy may increase the risk of hair loss.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Breathing in newborn rats is affected differently by hormones based on their sex.

Hair analysis shows low progesterone in anorexia patients, unchanged by short-term weight gain.

Phototrichogram helps assess hair loss severity.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

High doses of norethindrone acetate in rats caused various organ changes but didn't significantly increase tumor rates.

The ProScope HR is an effective, user-friendly, and affordable tool for diagnosing hair loss.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.